Robert I Tepper's Net Worth

$1.5 Billion

Estimate Recalculated Feb 22, 2024 04:42PM EST

Who is Robert I Tepper?

Robert I Tepper has an estimated net worth of $1.5 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Blueprint Medicines Corp, Nurix Therapeutics, Inc., bluebird bio, Inc., Global Blood Therapeutics, Inc., Sage Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., Foundation Medicine, Inc., ZAFGEN, INC., Cerulean Pharma Inc., Allena Pharmaceuticals, Inc., Decibel Therapeutics, Inc., Eleven Biotherapeutics, Inc., CytomX Therapeutics, Inc., Kala Pharmaceuticals, Inc., and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Robert I Tepper's CIK is 0001192595

Past Insider Trading and Trends

2015 was Robert I Tepper's most active year for acquiring shares with 30 total transactions. Robert I Tepper's most active month to acquire stocks was the month of May. 2017 was Robert I Tepper's most active year for disposing of shares, totalling 41 transactions. Robert I Tepper's most active month to dispose stocks was the month of December. 2018 saw Robert I Tepper paying a total of $4,079,104.60 for 3,046,765 shares, this is the most they've acquired in one year. In 2021 Robert I Tepper cashed out on 21,434,231 shares for a total of $322,683,542.21, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-25.12%
-1.00M
2.98M
Scheduled
Aug 30
Form 4
+22,487.15%
3.96M
3.98M
Oct 10
Form 3
0
0
No matching records found

Revolution Medicines, Inc. (RVMD) Snapshot price: $29.95

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-7.60%
-419.90K
$20.25
-$8,502,995.25
5.1M
Jun 8
Form 4
-100.00%
-543.11K
$30.21
-$16,406,962.48
0
Jun 3 - Jun 4
Form 4
-71.55%
-1.37M
$30.57
-$41,764,208.12
543.11K
May 25 - May 26
Form 4
-21.36%
-1.50M
5.52M
Feb 24
Form 4
-12.46%
-1.00M
7.02M
Dec 2
Form 4
-11.08%
-1.00M
8.02M
Sep 9
Form 4
+2,560.14%
10.52M
10.93M
Feb 18
Form 3
0
0
No matching records found

PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $16.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-52.09%
-2.00M
1.84M
Nov 29
Form 4
-34.25%
-2.00M
3.84M
Scheduled
Sep 20
Form 4
+2,750.00%
7.69M
7.97M
Jun 5
Form 3
0
0
No matching records found

Editas Medicine, Inc. (EDIT) Snapshot price: $7.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-16.11%
-750.00K
3.91M
Aug 16
Form 4
4.66M
4.66M
Feb 8
Form 3
0
0
No matching records found

Blueprint Medicines Corp (BPMC) Snapshot price: $77.17

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.45%
-1.00M
3.45M
Scheduled
Feb 27
Form 4
-18.34%
-1.00M
$35.28
-$35,275,000.00
4.45M
Feb 7
Form 4
-18.03%
-1.20M
5.45M
Apr 14
Form 4
-8.37%
-618.44K
6.77M
Nov 18
Form 4
+2,610.79%
7.12M
7.39M
May 5
Form 3
0
0
No matching records found